The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $203,471
- $1,410,800 in all
- Institutions
- 7
- 7 contact PIs
Awards by fiscal year
0
0
0
0
7
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- OHIO STATE UNIVERSITY1
- ROSWELL PARK CANCER INSTITUTE CORP1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF CHICAGO1
- UNIVERSITY OF CINCINNATI1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 RTRB-F (J3))3
- Special Emphasis Panel (ZCA1 SRB-5 (J2))2
- Special Emphasis Panel (ZCA1 SRB-5 (M1))1
- Special Emphasis Panel (ZCA1 SRB-K (J1))1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2018 | (PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?1R21CA227375-01 | Antoch, MarinaRepasky, Elizabeth A | ROSWELL PARK CANCER INSTITUTE CORP, NY | First-year cost $224,199 | Study section ZCA1 |
| FY2018 | (PQ6) Roles of circadian rhythms in tumor development1R21CA227379-01 | Hong, Christian I | UNIVERSITY OF CINCINNATI, OH | First-year cost $208,800 | Study section ZCA1 |
| FY2018 | (PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes1R21CA227232-01 | Atreya, Chloe E.Turnbaugh, Peter James | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $208,746 | Study section ZCA1 |
| FY2018 | Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome1R21CA219884-01A1 | Abdel-Rahman, Mohamed H. | OHIO STATE UNIVERSITY, OH | First-year cost $203,471 | Study section ZCA1 |
| FY2018 | Chronotherapy as a Strategy to Attenuate Toxicity Associated with Cisplatin and Radiation Treatment for Triple-Negative Breast Cancer1R21CA227381-01 | Gaddameedhi, Shobhan | WASHINGTON STATE UNIVERSITY, WA | First-year cost $199,665 | Study section ZCA1 |
| FY2018 | (PQ11) Dietary strategies to enhance FOLFOX cancer therapies1R21CA231255-01 | Rosenberg, Daniel William | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | First-year cost $189,744 | Study section ZCA1 |
| FY2018 | (PQ10) Understanding How Commensal Microbiota Affect the Anti-tumor Action of Radiotherapy1R21CA227528-01 | Weichselbaum, Ralph R | UNIVERSITY OF CHICAGO, IL | First-year cost $176,175 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.